Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study
- PMID: 22393473
- PMCID: PMC3291422
- DOI: 10.1258/shorts.2011.011119
Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study
Abstract
Objectives: To assess the impact on health-related quality of life (HRQoL) in adult cystic fibrosis (CF) patients of chronic infection with the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa).
Design: Cohort study.
Participants: Adult CF patients attending a single CF centre.
Setting: Outpatient clinic.
Main outcome measures: HRQoL measures of adult CF patients chronically infected with LES and Psa strains measured by CFQ-UK.
Results: Patients infected by transmissible Psa strains had worse physical functioning, respiratory symptoms, treatment burden, vitality, role, health perception and emotion than those with unique Psa strains (P < 0.01), and significantly poorer physical functioning, respiratory symptoms, treatment burden, body image, weight, role, and emotion than those without any Psa infection (P < 0.05). Furthermore, in a matched cohort of 39 patients, those with LES infection reported significantly worse physical functioning, treatment burden, respiratory symptoms and health perception than those with unique Psa infection (P < 0.02).
Conclusion: Chronic infection with transmissible Psa strains, particularly LES, confers a worse quality of life in adult CF patients. Coupled with the established poorer clinical outcome, this reinforces the need to prevent the spread of such strains in CF community.
References
-
- UK CF Registry Annual Data report 2008. Bromley: UK CF Trust, 2008
-
- Kerem E, Corey M, Gold R, Levison H Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714–19 - PubMed
-
- Henry RL, Mellis CM, Petrovic L Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158–61 - PubMed
-
- WHOQOL Group K The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403–9 - PubMed
-
- Cheng K, Smyth RL, Govan JR, et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639–42 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous